Olema Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
/ 
Frequently asked questions
To buy Olema Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Olema Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Olema Pharmaceuticals Inc. is OLMA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Olema Pharmaceuticals Inc. has its primary listing on NASDAQ. You can trade Olema Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Olema Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Olema Pharmaceuticals Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Olema Pharmaceuticals Inc..